Rivabazumab Reference: HY-P99953 Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV.
Phospho Tau Antibody Panel (Total, pS396, pS404) Reference: ARG30211 Phospho Tau antibody; Tau antibody; Tau phospho (Ser396) antibody; Tau phospho (Ser404) antibody
Lebrikizumab Reference: HY-P99025 Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma.
Phospho Tyrosine Hydroxylase Antibody Panel (Total, pS31, pS40) Reference: ARG30212 Phospho Tyrosine Hydroxylase antibody; Tyrosine Hydroxylase antibody; Tyrosine Hydroxylase phospho (Ser31) antibody; Tyrosine Hydroxylase phospho (Ser40) antibody
Topsalysin Reference: HY-P99554 Topsalysin (PRX-302; PRX302; PSA-PAH1) is a PSA-activated protoxin, a pore-forming protein (synthetic proaerolysin) fusion protein with human prostate-specific antigen. Topsalysin has tumor suppression effect in mice modle.
Anti-Mouse NK1.1 Antibody Reference: HY-P99143 Anti-Mouse NK1.1 Antibody is an anti-mouse NK1.1 IgG2a antibody inhibitor derived from host mouse.
Fremanezumab Reference: HY-P99019 Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research.
Burfiralimab Reference: HY-P99490 Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies.